Ultralife (ULBI) to Release Earnings on Thursday

Ultralife (NASDAQ:ULBI) is anticipated to post its Q2 2025 quarterly earnings results before the market opens on Thursday, July 24th. Analysts expect Ultralife to post earnings of $0.14 per share and revenue of $51.00 million for the quarter.

Ultralife (NASDAQ:ULBI) last announced its quarterly earnings data on Friday, May 9th. The technology company reported $0.13 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.15 by ($0.02). The business had revenue of $50.75 million during the quarter, compared to the consensus estimate of $54.50 million. Ultralife had a net margin of 3.05% and a return on equity of 4.61%. During the same quarter last year, the company earned $0.21 EPS.

Ultralife Stock Down 0.2%

Shares of NASDAQ:ULBI opened at $9.11 on Wednesday. The company has a debt-to-equity ratio of 0.37, a current ratio of 3.22 and a quick ratio of 1.70. The company has a market capitalization of $151.50 million, a PE ratio of 28.47 and a beta of 1.00. Ultralife has a 1 year low of $4.07 and a 1 year high of $12.40. The business has a fifty day moving average price of $7.67 and a two-hundred day moving average price of $6.60.

Wall Street Analyst Weigh In

Separately, Wall Street Zen raised Ultralife from a “buy” rating to a “strong-buy” rating in a report on Friday, June 6th.

Insider Buying and Selling

In related news, Director Bradford T. Whitmore acquired 16,063 shares of the stock in a transaction dated Wednesday, May 14th. The stock was acquired at an average cost of $5.47 per share, with a total value of $87,864.61. Following the purchase, the director directly owned 1,045,947 shares of the company’s stock, valued at approximately $5,721,330.09. This trade represents a 1.56% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Thomas Louis Saeli purchased 5,000 shares of Ultralife stock in a transaction dated Wednesday, May 14th. The stock was acquired at an average price of $5.44 per share, for a total transaction of $27,200.00. Following the completion of the acquisition, the director owned 85,000 shares of the company’s stock, valued at approximately $462,400. This trade represents a 6.25% increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders have purchased 47,140 shares of company stock valued at $256,355. 40.00% of the stock is owned by corporate insiders.

Institutional Trading of Ultralife

An institutional investor recently raised its position in Ultralife stock. Jones Financial Companies Lllp boosted its holdings in Ultralife Corporation (NASDAQ:ULBI) by 1,428.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 15,287 shares of the technology company’s stock after acquiring an additional 14,287 shares during the period. Jones Financial Companies Lllp owned 0.09% of Ultralife worth $82,000 at the end of the most recent reporting period. 30.68% of the stock is owned by hedge funds and other institutional investors.

About Ultralife

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.